{
  "ticker": "IFRX",
  "company_name": "InflaRx N.V.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03895801",
      "title": "Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)",
      "start_date": "2019-04-03",
      "completion_date": "2021-06-08",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT05964413",
      "title": "Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Pyoderma Gangrenosum",
      "start_date": "2023-11-01",
      "completion_date": "2025-07-11",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT04333420",
      "title": "Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Severe COVID-19 Pneumonia",
      "start_date": "2020-03-31",
      "completion_date": "2021-12-01",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT03001622",
      "title": "Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hidradenitis Suppurativa",
      "start_date": "2016-12",
      "completion_date": "2017-07",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT03712345",
      "title": "Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)",
      "start_date": "2018-10-15",
      "completion_date": "2021-05-03",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT06703073",
      "title": "JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome",
      "start_date": "2025-06-10",
      "completion_date": "2028-09",
      "enrollment": 0,
      "sponsor": "PPD Development, LP"
    },
    {
      "nct_id": "NCT03487276",
      "title": "Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hidradenitis Suppurativa (HS)",
      "start_date": "2018-02-26",
      "completion_date": "2020-01-27",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT03971643",
      "title": "Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Pyoderma Gangrenosum",
      "start_date": "2019-05-16",
      "completion_date": "2022-01-03",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT02246595",
      "title": "Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Severe Sepsis, Septic Shock",
      "start_date": "2014-04",
      "completion_date": "2015-12",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    },
    {
      "nct_id": "NCT02866825",
      "title": "Studying Complement Inhibition in Complex Cardiac Surgery",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Systemic Inflammatory Response Syndrome, C.Surgical Procedure; Cardiac",
      "start_date": "2016-05",
      "completion_date": "2017-01",
      "enrollment": 0,
      "sponsor": "InflaRx GmbH"
    }
  ],
  "summary": {
    "total_trials": 16,
    "by_phase": {
      "PHASE2": 13,
      "PHASE3": 1,
      "PHASE2, PHASE3": 1,
      "PHASE1": 1
    },
    "by_status": {
      "COMPLETED": 8,
      "TERMINATED": 3,
      "RECRUITING": 5
    },
    "active_trials": 5,
    "completed_trials": 8,
    "conditions": [
      "Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome",
      "Chronic Urticaria, Idiopathic, Hidradenitis, Hidradenitis Suppurativa",
      "Drug Safety",
      "Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)",
      "Hidradenitis Suppurativa",
      "Hidradenitis Suppurativa (HS)",
      "Pyoderma Gangrenosum",
      "SCC - Squamous Cell Carcinoma of Skin",
      "Severe COVID-19 Pneumonia",
      "Severe Sepsis, Septic Shock",
      "Systemic Inflammatory Response Syndrome, C.Surgical Procedure; Cardiac"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T13:12:12.823851",
    "search_query": "InflaRx N.V.",
    "url": "https://clinicaltrials.gov/search?term=InflaRx+N.V."
  }
}